Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 1;6(4):323-333.
doi: 10.1517/17530059.2012.686996. Epub 2012 May 8.

Risk Factors of Follicular Lymphoma

Affiliations

Risk Factors of Follicular Lymphoma

Shuangge Ma. Expert Opin Med Diagn. .

Abstract

INTRODUCTION: Non-Hodgkin Lymphoma (NHL) is a heterogeneous group of malignancies with over thirty different subtypes. Follicular lymphoma (FL) is the most common form of indolent NHL and the second most common form of NHL overall. It has morphologic, immunophenotypic and clinical features significantly different from other subtypes. Considerable effort has been devoted to the identification of risk factors for etiology and prognosis of FL. These risk factors may advance our understanding of the biology of FL and have an impact on clinical practice. AREAS COVERED: The epidemiology of NHL and FL is briefly reviewed. For FL etiology and prognosis separately, we review clinical, environmental and molecular (including genetic, genomic, epigenetic and others) risk factors suggested in the literature. EXPERT OPINION: A large number of potential risk factors have been suggested in recent studies. However, there is a lack of consensus, and many of the suggested risk factors have not been rigorously validated in independent studies. There is a need for large-scale, prospective studies to consolidate existing findings and discover new risk factors. Some of the identified risk factors are successful at the population level. More effective individual-level risk factors and models remain to be identified.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest

The author declares no conflict of interest.

Similar articles

Cited by

References

    1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review. National Cancer Institute; Bethesda, MD: 1975–2008. based on November 2010 SEER data submission.
    1. Ekstrom-Smedby K. Epidemiology and etiology of Non-Hodgkin lymphoma: a review. Acta Oncol. 2006;45:258–271. Epidemiology of NHL and FL. - PubMed
    1. Jaffe ES, Harris NL, Stain H, et al. Tumors of haematopoietic and lymphoid tissues. IRAC; Lyon: 2001. World Health Organization of classification of tumors. WHO classification of FL.
    1. Turner JJ, Hughes AM, Kricker A, et al. WHO Non-Hodgkin’s Lymphoma classification by criterion-based report review followed by targeted pathology review an effective strategy for epidemiology studies. Cancer Epidemiology, Biomarkers & Prevention. 2005;14:2213–2219. - PubMed
    1. Freedman A. Follicular lymphoma: 2011 update on diagnosis and management. Am J Hematol. 2011;86:768–775. Recent comprehensive review of diagnosis and treatment. - PubMed

LinkOut - more resources